A Study to Investigate Safety and Tolerability of NDX-3315 and NDX-3324 in Healthy Participants and Patients With Eosinophilic Esophagitis
Clinical trial NCT05757856 · COMPLETED
Trial details
- NCT number
- NCT05757856
- Sponsor
- NexEos Diagnostics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-20
- Primary completion
- 2025-05-22
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.